Radiation therapy for prostate cancer: the role for dose escalation

Michael J Swartz; Kristin Janson; Theodore L Deweese; Danny Y Song

doi:10.1007/s12019-007-8014-7

Radiation therapy for prostate cancer: the role for dose escalation

Compr Ther. 2007 Winter;33(4):216-22. doi: 10.1007/s12019-007-8014-7.

Authors

Michael J Swartz¹, Kristin Janson, Theodore L Deweese, Danny Y Song

Affiliation

¹ Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

PMID: 18025613
DOI: 10.1007/s12019-007-8014-7

Abstract

Recent technological advances in radiation treatment delivery have allowed relatively higher doses of radiation to be delivered safely to the prostate. Emerging data suggest improvements in disease control with higher doses of radiation in subsets of patients with prostate cancer.

MeSH terms

Angiogenesis Inhibitors / therapeutic use
Brachytherapy
Combined Modality Therapy
Dose-Response Relationship, Radiation
Humans
Male
Prostatic Neoplasms / radiotherapy*
Prostatic Neoplasms / therapy
Radiotherapy Dosage
Risk Assessment

Substances

Angiogenesis Inhibitors